FIELD: medicine; veterinary medicine.
SUBSTANCE: method involves using biologically active substances obtainable by means of bacteriological synthesis. Individual avermectines or their complexes are applied in vitro in concentrations of 0.01-10 ng/ml and in vivo at a dose of 0.01-1 mg/kg.
EFFECT: enhanced effectiveness of treatment; reduced toxic effect.
4cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ISOLATION OF AVERMECTIN COMPLEXES | 2000 |
|
RU2182174C2 |
| PREPARATION FOR PROTECTION OF ANIMALS AND PLANTS | 2000 |
|
RU2201244C2 |
| ANTIPARASITIC VETERINARY INJECTION PREPARATION | 2000 |
|
RU2201243C2 |
| ANTI-PARASITIC AGENT | 1999 |
|
RU2160536C1 |
| ANTIPARASITIC PREPARATION FOR NEEDLE-FREE INJECTION | 2003 |
|
RU2251421C2 |
| METHOD OF DETERMINING MICROQUANTITIES OF AVERMECTINES IN ANIMAL- AND VEGETABLE- ORIGIN FOODSTUFFS | 2001 |
|
RU2207547C1 |
| MEANS FOR CONTROL OF SYNANTROPIC INSECTS | 1999 |
|
RU2159040C1 |
| AGENT SUPPRESSING PROLIFERATION AND CAUSING DEATH OF TUMOR CELLS AND PROTECTING NORMAL CELLS | 1997 |
|
RU2138268C1 |
| STRAIN OF ACTINOMYCETES STREPTOMYCES AVERMITILIS CCM 4697 AS PRODUCER OF AVERMECTINS | 1998 |
|
RU2156301C2 |
| ANTI PARASITE MEDICATION FOR TREATMENT OF DOGS AND CATS | 2006 |
|
RU2356562C2 |
